BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
Not yet recruiting · NCT07544160 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-22 | NCT07544160 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| iCAR Bio Therapeutics Ltd. | 2 |
| iCell Gene Therapeutics | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan People's Hospital | Zhongshan | China | 14 |